🇺🇸 FDA
Pipeline program

D-Galactose

4657

Unknown small_molecule completed

Quick answer

D-Galactose for Focal Segmental Glomerulosclerosis is a Unknown program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Focal Segmental Glomerulosclerosis
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials